• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Voice Preservation

Making Our Voices Heard

Speech is a key part of a person’s identity. Voice matters to personal identity and expression, and connection with family and friends. The majority of people living with ALS/MND are eventually robbed of this fundamental part of their humanity.

This can be overcome using voice preservation technologies, but our research shows this is not equitably accessible. The Alliance seeks to provide universal access to technology to improve the quality of life of people living with ALS/MND. The ideal for every individual living with ALS/MND worldwide is to have the right to access voice preservation upon diagnosis.

The Voice Preservation Project

The Alliance, through a collaboration between Hospital Universitario Nacional de Colombia (HUN) and the Asociación Colombiana de ELA (ACELA), has launched a pilot project to deliver voice preservation technology to people living with ALS/MND in Colombia. This will serve as the basis on which future plans will be made on how best to scale to reach more people around the world.

If you would like to join us in expanding our reach to more people, please donate. We deeply appreciate your support.

Watch this video to find out more from the Alliance and its Information Technology Advisory Council (ITAC).

https://www.als-mnd.org/wp-content/uploads/2023/06/Voice-Preservation-ITAC-Intro.mp4

Watch this video to hear from Orlando Ruiz, founder of ACELA and a person living with ALS/MND, as he emphasizes the devastation of losing your voice. He goes on to explain the potential of voice banking technology to preserve dignity, autonomy and identity, and ensure no one loses their voice to ALS/MND.

 

Keep Up To Date

This project is in development and more details and information are coming soon! If you are interested in learning more, sign up to get periodic updates as the work progresses.

Subscribe

* indicates required
 
 

 

Disclaimer: Voice preservation is not designed, intended or made available for diagnosis, treatment or prevention of diseases or for use as a medical device. It is also not designed or intended to replace or be a substitute for professional medical advice, diagnosis, treatment or judgment.

Primary Sidebar

  • Mike Cels, Canada

    Mike Cels, Canada

  • Maria Santos Garcia Tellez, Mexico

    Maria Santos Garcia Tellez, Mexico

  • Liong Ting Ngu, Malaysia

    Liong Ting Ngu, Malaysia

  • Yolanda Armendariz, Mexico

    Yolanda Armendariz, Mexico

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • Osiel Mendoza, USA

    Osiel Mendoza, USA

  • Inta Grubb, Australia

    Inta Grubb, Australia

  • Jon Newsome, USA

    Jon Newsome, USA

  • Kirsty Gerlach, New Zealand

    Kirsty Gerlach, New Zealand

  • Paul Launer, USA

    Paul Launer, USA

  • Elkin Gaviria, Colombia

    Elkin Gaviria, Colombia

  • Richard Clark, New Zealand

    Richard Clark, New Zealand

  • Gisli Jonasson, Iceland

    Gisli Jonasson, Iceland

  • Steve

    Steve

  • Alfredo Santos, Colombia

    Alfredo Santos, Colombia

  • Gudjon Sigurdsson, Iceland

    Gudjon Sigurdsson, Iceland

  • Timothy Holman, Switzerland

    Timothy Holman, Switzerland

  • Bob Spurrier, USA

    Bob Spurrier, USA

  • Federica Mastrosimone, Italy

    Federica Mastrosimone, Italy

  • Kirsten Harley, Australia

    Kirsten Harley, Australia

  • Jason Goodman, USA

    Jason Goodman, USA

  • Motoko Ogasawara, Japan

    Motoko Ogasawara, Japan

  • Marco Antonio Alvarez Mercado, Mexico

    Marco Antonio Alvarez Mercado, Mexico

  • Chirag Walia, India

    Chirag Walia, India
    ChiragWalia

  • Animesh Kumar, India

    Animesh Kumar, India

  • Feng Gin Sun, China

    Feng Gin Sun, China

  • Christian Bär, Germany

    Christian Bär, Germany

  • Anderson Custodio Pinto, Brazil

    Anderson Custodio Pinto, Brazil

  • David Watson, Scotland

    David Watson, Scotland

  • Ismail Gokcek, Turkey

    Ismail Gokcek, Turkey
    ismail_gokcek_alsmnd_tr

  • Norm MacIsaac, Canada

    Norm MacIsaac, Canada

  • Liam Dwyer, England

    Liam Dwyer, England

  • Anthony Lynch, Australia

    Anthony Lynch, Australia

  • Angelique van der Lit-van Veldhuizen, Netherlands

    Angelique van der Lit-van Veldhuizen, Netherlands

  • Dr. Janmejay Pradhan, India

    Dr. Janmejay Pradhan, India

  • Camilla Heiberg Freiberg, Denmark

    Camilla Heiberg Freiberg, Denmark

  • PALS and CALS, Singapore

    PALS and CALS, Singapore

  • Angela Jansen, Germany

    Angela Jansen, Germany

  • Maurice Leclerc, Canada

    Maurice Leclerc, Canada

  • Fabio Correia, Brazil

    Fabio Correia, Brazil

  • Jack Buzby, USA

    Jack Buzby, USA

  • Yannick Richard, Canada

    Yannick Richard, Canada
    yannickrichard

  • Magdalena Ayala Rodríguez, Mexico

    Magdalena Ayala Rodríguez, Mexico

  • Daniel Hare, USA

    Daniel Hare, USA

  • Colm Francis Davis, Ireland

    Colm Francis Davis, Ireland

  • Guido De Mets, Belgium

    Guido De Mets, Belgium

  • Cliff Marshman, USA

    Cliff Marshman, USA
    CliffMarshman

  • Shaleen Latchman, Canada

    Shaleen Latchman, Canada

  • Hanne Stenmose, Denmark

    Hanne Stenmose, Denmark

  • Mauril Belanger, Canada

    Mauril Belanger, Canada

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login